These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3500055)

  • 1. High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type I interferon (alpha, beta), on lymphoblastoid cells.
    Coulie PG; Vanhecke A; Van Damme J; Cayphas S; Poupart P; De Wit L; Content J
    Eur J Immunol; 1987 Oct; 17(10):1435-40. PubMed ID: 3500055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor.
    Van Damme J; De Ley M; Van Snick J; Dinarello CA; Billiau A
    J Immunol; 1987 Sep; 139(6):1867-72. PubMed ID: 3305707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.
    Kirnbauer R; Köck A; Schwarz T; Urbanski A; Krutmann J; Borth W; Damm D; Shipley G; Ansel JC; Luger TA
    J Immunol; 1989 Mar; 142(6):1922-8. PubMed ID: 2784142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-beta 2, and is inhibited by specific antibodies to IFN-beta.
    Reis LF; Le JM; Hirano T; Kishimoto T; Vilcek J
    J Immunol; 1988 Mar; 140(5):1566-70. PubMed ID: 3279118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
    Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple cytokines inhibit interleukin-6-dependent murine hybridoma/plasmacytoma proliferation.
    Schwabe M; Cox GW; Bosco MC; Prohaska R; Kung HF
    Cell Immunol; 1996 Feb; 168(1):117-21. PubMed ID: 8599834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific binding of human alpha interferon to high-affinity cell-surface binding sites on peripheral blood mononuclear cells.
    Dooley JS; Vergalla J; Hoofnagle JH; Zoon KC; Munson PJ; Jones EA
    J Lab Clin Med; 1989 May; 113(5):623-31. PubMed ID: 2523945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and regulation of interleukin 6 in human B lymphoid cells.
    Hutchins D; Cohen BB; Steel CM
    Eur J Immunol; 1990 May; 20(5):961-8. PubMed ID: 2113479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 1 and poly(rI).poly(rC) induce production of a hybridoma growth factor by human fibroblasts.
    Van Damme J; Cayphas S; Opdenakker G; Billiau A; Van Snick J
    Eur J Immunol; 1987 Jan; 17(1):1-7. PubMed ID: 3545852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.
    Scheurich P; Thoma B; Ucer U; Pfizenmaier K
    J Immunol; 1987 Mar; 138(6):1786-90. PubMed ID: 3029221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor.
    Tsujimoto M; Yip YK; Vilcek J
    J Immunol; 1986 Apr; 136(7):2441-4. PubMed ID: 3005410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
    Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC
    Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 production by human liver (myo)fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1 beta and TNF alpha.
    Tiggelman AM; Boers W; Linthorst C; Brand HS; Sala M; Chamuleau RA
    J Hepatol; 1995 Sep; 23(3):295-306. PubMed ID: 8550994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of the interferon-beta 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines.
    Walther Z; May LT; Sehgal PB
    J Immunol; 1988 Feb; 140(3):974-7. PubMed ID: 3276786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
    Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
    J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of gamma-interferon receptors.
    Raitano AB; Korc M
    Cancer Res; 1993 Feb; 53(3):636-40. PubMed ID: 8425199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the human type I interferon receptor by ligand blotting.
    Schwabe M; Princler GL; Faltynek CR
    Eur J Immunol; 1988 Dec; 18(12):2009-14. PubMed ID: 2975600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.
    Matsuda T; Hirano T; Kishimoto T
    Eur J Immunol; 1988 Jun; 18(6):951-6. PubMed ID: 3260187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of type I IFN and IFN-gamma on the binding of tumor necrosis factor to receptors in two human cell lines.
    Tsujimoto M; Feinman R; Vilcek J
    J Immunol; 1986 Oct; 137(7):2272-6. PubMed ID: 3020123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.